Search alternatives:
greater decrease » greater increase (Expand Search), greater increases (Expand Search), rate decreased (Expand Search)
treat diseases » heart diseases (Expand Search), leaf diseases (Expand Search), streak disease (Expand Search)
mean decrease » a decrease (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), gy decreased (Expand Search)
Showing 1 - 20 results of 62,565 for search '(( third ((mean decrease) OR (((greater decrease) OR (nn decrease)))) ) OR ( _ treat diseases ))', query time: 0.58s Refine Results
  1. 1
    Candidates from the RF method. The top 25 random forest candidates ranked by mean decrease in accuracy and mean decrease in Gini Index are in the first and second columns, respectively. The third column contains candidates common to both columns, sorted according to start position. The identifier of the peptide consists of the start to stop position within the sequence of the spike protein from ancestral SARS-CoV-II.

    Candidates from the RF method. The top 25 random forest candidates ranked by mean decrease in accuracy and mean decrease in Gini Index are in the first and second columns, respectively.... by Zoë Parker Cates (22184243)

    Published 2025
    “…The top 25 random forest candidates ranked by mean decrease in accuracy and mean decrease in Gini Index are in the first and second columns, respectively. …”
    Save to List
    Saved in:
  2. 2
    Hyperuricemia and chronic kidney disease: to treat or not to treat

    Hyperuricemia and chronic kidney disease: to treat or not to treat by Federica Piani (10468170)

    Published 2022
    Save to List
    Saved in:
  3. 3
    Hyperuricemia and chronic kidney disease: to treat or not to treat

    Hyperuricemia and chronic kidney disease: to treat or not to treat by Federica Piani (10468170)

    Published 2021
    Save to List
    Saved in:
  4. 4
    Boxplots with data distribution, mean, median, and first and third quartiles, visualizing changes in all CMJ and DJ metrics across the three time-points analyzed.

    Boxplots with data distribution, mean, median, and first and third quartiles, visualizing changes in all CMJ and DJ metrics across the three time-points analyzed. by Nicolas M. Philipp (13272198)

    Published 2023
    Save to List
    Saved in:
  5. 5
    Boxplots with mean median and first and third quartiles visualizing changes in all CMJ and DJ metrics across the three time-points, broken down by RSA classification.

    Boxplots with mean median and first and third quartiles visualizing changes in all CMJ and DJ metrics across the three time-points, broken down by RSA classification. by Nicolas M. Philipp (13272198)

    Published 2023
    Save to List
    Saved in:
  6. 6
    Reasons for decreasing fear towards COVID-19.

    Reasons for decreasing fear towards COVID-19. by Misganu Endriyas (5581679)

    Published 2023
    Save to List
    Saved in:
  7. 7
    How I treat Parkinson's disease

    How I treat Parkinson's disease by Egberto Reis Barbosa (6142820)

    Published 2022
    Save to List
    Saved in:
  8. 8
    Demographic and disease characteristics of the intention-to-treat population.

    Demographic and disease characteristics of the intention-to-treat population. by Peter Joseph Jongen (7485752)

    Published 2019
    “…<p>Demographic and disease characteristics of the intention-to-treat population.…”
    Save to List
    Saved in:
  9. 9
    Can we treat Alzheimer's disease at an early stage?

    Can we treat Alzheimer's disease at an early stage? by Chandni Tiwari (9123199)

    Published 2020
    Save to List
    Saved in:
  10. 10
    Cost of care to the hospital for treating cardiovascular diseases patients.

    Cost of care to the hospital for treating cardiovascular diseases patients. by Atul Kumar (1479058)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  11. 11
    Cellular viability of ergothioneine-treated hDPSCs.

    Cellular viability of ergothioneine-treated hDPSCs. by Amarin Thongsuk (21485401)

    Published 2025
    Save to List
    Saved in:
  12. 12
    Diagnosing and Treating Depression in Patients with Alzheimer’s Disease

    Diagnosing and Treating Depression in Patients with Alzheimer’s Disease by Anna D. Burke (7025537)

    Published 2019
    Save to List
    Saved in:
  13. 13
    Diarrheal disease severity by treatment group for the modified intent-to-treat population.

    Diarrheal disease severity by treatment group for the modified intent-to-treat population. by Rahsan Erdem (11726357)

    Published 2021
    “…<p>Diarrheal disease severity by treatment group for the modified intent-to-treat population.…”
    Save to List
    Saved in:
  14. 14
    Phenolic Lipids Derived from Cashew Nut Shell Liquid to Treat Metabolic Diseases

    Phenolic Lipids Derived from Cashew Nut Shell Liquid to Treat Metabolic Diseases by Cigdem Sahin (6653825)

    Published 2022
    Save to List
    Saved in:
  15. 15
    Phenolic Lipids Derived from Cashew Nut Shell Liquid to Treat Metabolic Diseases

    Phenolic Lipids Derived from Cashew Nut Shell Liquid to Treat Metabolic Diseases by Cigdem Sahin (6653825)

    Published 2022
    Save to List
    Saved in:
  16. 16
    Oxazole-Based Ferroptosis Inhibitors with Promising Properties to Treat Central Nervous System Diseases

    Oxazole-Based Ferroptosis Inhibitors with Promising Properties to Treat Central Nervous System Diseases by Camilla Scarpellini (5508635)

    Published 2025
    Save to List
    Saved in:
  17. 17
    Phenolic Lipids Derived from Cashew Nut Shell Liquid to Treat Metabolic Diseases

    Phenolic Lipids Derived from Cashew Nut Shell Liquid to Treat Metabolic Diseases by Cigdem Sahin (6653825)

    Published 2022
    Save to List
    Saved in:
  18. 18
    Phenolic Lipids Derived from Cashew Nut Shell Liquid to Treat Metabolic Diseases

    Phenolic Lipids Derived from Cashew Nut Shell Liquid to Treat Metabolic Diseases by Cigdem Sahin (6653825)

    Published 2022
    Save to List
    Saved in:
  19. 19
    AST levels in pre-treat HIV and HIV co-infected patients with other diseases.

    AST levels in pre-treat HIV and HIV co-infected patients with other diseases. by Wudi Wei (2816626)

    Published 2025
    Save to List
    Saved in:
  20. 20
    Descriptive statistics (median [first-third quartile]) grouped by Half (first vs second half) and Time (pre-, post- and 24h post-training).

    Descriptive statistics (median [first-third quartile]) grouped by Half (first vs second half) and Time (pre-, post- and 24h post-training). by Davide Curzi (466778)

    Published 2024
    Save to List
    Saved in:

Search Tools: